- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Mar 27, 2020 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Mar 31, 2020 | T-1527-18 | TMC | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Ottawa | 2 h |
| Mar 31, 2020 | T-1529-18 | TMC | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Ottawa | 2 h |
| Apr 1, 2020 | A-15-20 | APP | Teva Canada Limited V. Bayer Inc Et Al. (Patent - Xarelto*) | Ottawa | 3 h |
| Apr 1, 2020 | A-16-20 | APP | Apotex Inc. V Bayer Inc.et Al (Patent - Rivaroxaban*) | Ottawa | 3 h |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Apr 20, 2020 | T-1069-14 | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 10 d |
| May 4, 2020 | T-569-17 | J.r. Simplot Company V. Mccain Foods Ltd. V. Simplot Canada (ii) Limited (Trade Mark) | Toronto | 7 d |
| May 11, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 13 d |
| May 13, 2020 | T-133-18 | Alexander Stross V. Polly Reitze Personal Real Estate Corporation, Et Al. (Copyright) | Calgary | 1 d |
| May 25, 2020 | T-206-18 | Rovi Guides, Inc. Et Al V. Telus Corporation Et Al (Patent) | Toronto | 20 d |
| May 25, 2020 | T-113-18 | Rovi Guides Inc Et Al V. Bce Inc. Et Al (Patent) | Toronto | 20 d |
| Jun 1, 2020 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Winnipeg | 12 d |
| Jun 1, 2020 | T-448-17 | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 14 d |
| Jun 15, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 10 d |
| Jul 15, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Toronto | 3 d |
| Aug 24, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 24, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 31, 2020 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 14 d |
| Sep 1, 2020 | T-806-19 | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 14, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-205-19 | Triteq Lock & Security, Llc V. Minus Forty Technologies Corp. (Patent) | Toronto | 5 d |
| Sep 17, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Toronto | 2 d |
| Sep 21, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 2 d |
| Oct 13, 2020 | T-902-19 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 8 d |
| Oct 13, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Toronto | 2 d |
| Oct 13, 2020 | T-954-18 | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 13 d |
| Oct 19, 2020 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Oct 26, 2020 | T-182-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-84-19 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-1893-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-978-19 | Janssen Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Abiraterone*) | Toronto | 20 d |
| Nov 9, 2020 | T-902-19 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 2 d |
| Nov 16, 2020 | T-202-17 | Travel Leaders Group, Llc V. 204293 Ontario Inc. Dba Travel Leaders (Trade Mark) | Toronto | 15 d |
| Nov 16, 2020 | T-227-17 | Dtechs Epm Ltd. V. British Columbia Hydro And Power Authority Et Al. (Patent) | Vancouver | 10 d |
| Nov 23, 2020 | T-917-17 | Sse Holdings, Llc Et Al V. Le Chic Shack Inc. (Trade Mark) | Québec | 5 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Nov 30, 2020 | T-1158-18 | Maoz Betser-zilevitch V. Petrochina Canada Ltd. (Patent) | Toronto | 12 d |
| Jan 11, 2021 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Ottawa | 5 d |
| Jan 11, 2021 | T-708-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-706-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - PIRFENIDONE*) | Toronto | 10 d |
| Jan 11, 2021 | T-705-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-704-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 18, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Montréal | 40 d |
| Feb 1, 2021 | T-794-19 | Allergan Inc. Et Al V. Apotex Inc. (Patent - Risedronate*) | Toronto | 10 d |
| Feb 1, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 30 d |
| Feb 1, 2021 | T-806-19 | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Ottawa | 5 d |
| Feb 1, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 5 d |
| Feb 8, 2021 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Feb 15, 2021 | T-152-17 | Milano Pizza Ltd. V. 6034799 Canada Inc Et Al (Trade Mark) | Ottawa | 7 d |
| Feb 15, 2021 | T-1008-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-1007-19 | Hoffmann-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-943-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-942-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-941-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-939-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-899-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-898-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-897-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-896-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-770-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-768-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Mar 8, 2021 | T-396-13 | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 10 d |
| Mar 15, 2021 | T-405-18 | Copperhead Industrial Inc. Et Al V. Changer & Dresser Inc. Et Al (Patent) | Toronto | 10 d |
| Mar 15, 2021 | T-1545-17 | Copperhead Industrial Inc. Et Al. V. Changer & Dresser Inc. (Patent) | Toronto | 10 d |
| Mar 15, 2021 | T-1817-16 | Copperhead Industrial Inc. Et Al V. Changer & Dresser Inc. Et Al (Patent) | Toronto | 10 d |
| Mar 15, 2021 | T-1202-16 | 002152706 Ontario Ltd Et Al V. Changer & Dresser Inc. (Patent) | Toronto | 10 d |
| Mar 22, 2021 | T-1187-19 | Bayer Inc. And Other V. Dr. Reddy's Laboratories Ltd And Others (Patent - Rivaroxaban*) | Ottawa | 9 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| May 11, 2020 | T-1400-19 | Sim & Mcburney V. Gayle Gordon | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| May 11, 2020 | T-1148-19 | 387191 Alberta Ltd. And Holy Grill Inc. V. Chef Aleem Inc. | Trade Mark Expungement | Calgary | 1 h |
| May 12, 2020 | T-1353-19 | Natco Pharma (canada) Inc. V. Min Health & Agc & Gilead Sciences Canada Inc. - Emtricitabine* | S. 18.1 Application for Judicial Review | Toronto | 3 h |
| May 26, 2020 | T-1404-19 | Yves Choueifaty V. Attorney General Et Al | Patent - Appeal of a Decision of Commissioner | Ottawa | 4 h |
| May 27, 2020 | T-1813-19 | Alfasigma S.p.a. V. Attorney General Of Canada Et Al - Rifaximin* | Statutory Appeal (code not provided elsewhere) | Toronto | 1 h |
| Jun 1, 2020 | T-1465-19 | Innovative Medicines Canada Et Al V. Agc | S. 18.1 Application for Judicial Review | Toronto | 2 d |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Apr 1, 2020 | A-15-20 | Teva Canada Limited V. Bayer Inc Et Al. - Xarelto* | Appeal (S.27 - Interloc.) - Patent Act | Ottawa | 3 h |
| Apr 1, 2020 | A-16-20 | Apotex Inc. V Bayer Inc.et Al - Rivaroxaban* | Appeal (S.27 - Interloc.) - Patent Act | Ottawa | 3 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.